Invasive ductal carcinoma of the breast grade II cure rate is high

Cancer cure generally refers to clinical cure. Whether the clinical cure rate of grade II invasive ductal carcinoma of the breast is high needs to be analyzed according to specific circumstances.

For early stage invasive ductal carcinoma of the breast, the focus is relatively limited, and timely surgical resection is accepted. Postoperative chemotherapy, such as paclitaxel, cyclophosphamide, carboplatin, etc., generally has a higher clinical cure rate. However, for advanced invasive ductal carcinoma of the breast, the disease is more severe, and multiple metastases such as liver, lung, brain tissue, etc., the clinical cure rate is lower.